Almonty's Valuation Soars to 147x Sales as Tungsten Decoupling Narrative Fuels 600% Rally
23.05.2026 - 20:41:09 | boerse-global.de
Almonty Industries has become a litmus test for the disconnect between narrative and reality in critical minerals investing. The Canadian tungsten miner, which generated just $50 million in revenue over the past twelve months, now commands a market capitalization of $7.35 billion — a price-to-sales multiple of 147. That number is not a typo, and it encapsulates the enormous expectations baked into the stock.
The shares closed last Friday at $25.80 on the TSX, capping a week that saw a net gain of roughly 7.4%. The path to that finish line was far from smooth. After slumping to $23.69 on Monday, the stock recovered steadily, hitting a weekly peak of $25.89 on Wednesday before easing into the close. Trading volumes tell a cautionary tale: more than 572,000 shares changed hands on Monday's selloff, but by Friday volume had dwindled to just over 410,000. The rebound came after a heavy selling session, not from a surge of fresh buying conviction.
A business turning the corner
Yet beneath the extreme valuation, Almonty's operating performance is starting to offer tangible evidence that the thesis may hold water. First-quarter results for 2026 delivered a step change: revenue of $25.4 million, up 221% year over year, driven by higher ammonium paratungstate (APT) spot prices and production from the Panasqueira mine in Portugal. Adjusted EBITDA swung from a loss of $2.4 million to a gain of $6.1 million. More critically, operating cash flow turned positive at $9.7 million, compared with a negative $4.4 million in Q1 2025.
Should investors sell immediately? Or is it worth buying Almonty?
The quarterly net loss of $5.3 million — though still a red ink item — was largely attributable to non-cash mark-to-market adjustments on derivative liabilities, not to operational deterioration. On the balance sheet, Almonty sits on net cash of approximately $94.5 million, with $260 million in cash against $165 million in debt, providing a cushion as it ramps up its flagship project.
Tungsten: the geopolitical catalyst that won't go away
The fundamental driver behind Almonty's stellar share price performance — a 611% year-on-year gain and a 114% advance since January — is the explosion in tungsten prices. APT, the key intermediate processing product, now trades at roughly $3,185 per metric ton unit, representing a 900% surge over the past twelve months. Structural supply constraints underpin this move: China controls an estimated 80% of global tungsten output, and U.S. legislation will ban the procurement of Chinese tungsten for government purposes from January 1, 2027.
Washington has already begun mobilizing to secure alternative supply. The "Project Vault" strategic mineral reserve program comes with a $12 billion price tag, backed by $10 billion in loans from the U.S. Export-Import Bank and $1.67 billion in private commitments from industrial giants including Boeing, General Motors, and Stellantis. The aim is to insulate civilian supply chains from geopolitical disruption — and Almonty is positioning itself as one of the few non-Chinese producers with scale.
Sangdong: delivery date looms
The company has completed Phase 1 of its Sangdong mine in South Korea, a facility designed to produce 2,300 tonnes of tungsten concentrate annually. That output would make Almonty one of the largest Western tungsten suppliers, directly feeding into the decoupling narrative. The real test arrives in 2027, when the U.S. procurement ban kicks in and Sangdong must prove it can deliver reliably to a hungry market.
The broader critical minerals sector has rallied alongside Almonty. Rare earth and cobalt stocks posted gains between 5% and 10% in the same week, and companies such as Western Star Resources are applying for Pentagon funding to develop domestic projects in Nevada.
Almonty at a turning point? This analysis reveals what investors need to know now.
Technicals flag near-term caution
At $25.80, Almonty's stock sits just below its 50-day moving average of $26.04. The relative strength index stands at 70.4, indicating that the recent recovery has pushed the shares into slightly overbought territory. With the 200-day average still far below at $15.61, the magnitude of the year-long run is evident. So is the volatility: the 30-day annualized figure of nearly 95% serves as a stark reminder that any investment here comes with violent swings.
The next quarterly earnings report will need to show whether Almonty can sustain the operational momentum from Q1. At a price-to-sales ratio of 147, the market is already pricing in a fundamental transformation — one that requires Sangdong to ramp smoothly, tungsten prices to hold, and the geopolitical tailwinds to remain strong. One strong quarter is not enough; the stock's current valuation demands proof, not promise.
Ad
Almonty Stock: New Analysis - 23 May
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
